The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series

T Cell ◽

Cell Therapy ◽

Pediatric Acute Lymphoblastic Leukemia

Fusion Gene ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Case Series ◽

T Cell Therapy ◽

Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia

Current Opinion in Hematology ◽

10.1097/moh.0000000000000685 ◽

2021 ◽

Vol 28 (6) ◽

pp. 373-379

Author(s):

Muna Qayed ◽

Marie Bleakley ◽

Nirali N. Shah

Keyword(s):

T Cell ◽

Cell Therapy ◽

Pediatric Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Bridge To Transplantation ◽

T Cell Therapy ◽

Extracorporeal Membrane Oxygenation as a Bridge to Chimeric Antigen Receptor T-cell Therapy for Severe Refractory Sepsis in the Setting of Relapsed Refractory Pediatric Acute Lymphoblastic Leukemia

Critical Care Explorations ◽

10.1097/cce.0000000000000093 ◽

2020 ◽

Vol 2 (4) ◽

pp. e0093

Author(s):

Alyssa Stoner ◽

Jenna O. Miller ◽

Terrie Flatt ◽

Jessica S. Wallisch

Keyword(s):

T Cell ◽

Cell Therapy ◽

Extracorporeal Membrane Oxygenation ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Pediatric Acute Lymphoblastic Leukemia ◽

Membrane Oxygenation

Cluster of differentiation 19 chimeric antigen receptor T‑cell therapy in pediatric acute lymphoblastic leukemia (Review)

Oncology Letters ◽

10.3892/ol.2020.11897 ◽

2020 ◽

Author(s):

Zexin Fu ◽

Jinlei Zhou ◽

Rui Chen ◽

Yihua Jin ◽

Ting Ni ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Pediatric Acute Lymphoblastic Leukemia ◽

Cluster Of Differentiation

Acute Kidney Injury after Chimeric Antigen Receptor T-Cell Therapy for Pediatric Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.307 ◽

2019 ◽

Vol 25 (3) ◽

pp. S168-S169 ◽

Cited By ~ 1

Author(s):

Regina M. Myers ◽

Julie Fitzgerald ◽

Caitlin W. Elgarten ◽

Kelly D. Getz ◽

Yimei Li ◽

...

Keyword(s):

Acute Kidney Injury ◽

T Cell ◽

Cell Therapy ◽

Pediatric Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Kidney Injury ◽

T Cell Therapy ◽

The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor–T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma

Cytotherapy ◽

10.1016/j.jcyt.2020.01.015 ◽

2020 ◽

Vol 22 (4) ◽

pp. 214-226 ◽

Cited By ~ 3

Author(s):

Jun-Xia Cao ◽

Hui Wang ◽

Wei-Jian Gao ◽

Jia You ◽

Li-Hua Wu ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

T Cell Therapy

Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia

The Cancer Journal ◽

10.1097/ppo.0000000000000508 ◽

2021 ◽

Vol 27 (2) ◽

pp. 98-106

Author(s):

Jordan Gauthier ◽

Cameron J. Turtle

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Cell Acute Lymphoblastic Leukemia

Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Acute Lymphoblastic Leukemia (B-ALL)

10.1007/978-3-030-78311-2_11 ◽

2021 ◽

pp. 179-196

Author(s):

Geoffrey Shouse ◽

Elizabeth Budde ◽

Stephen Forman

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy ◽

Car T Cell ◽

Car T Cell Therapy ◽

Car T

Abstract 1630: FLT3 chimeric antigen receptor T cell therapy induces B to T cell lineage switch in infant acute lymphoblastic leukemia

10.1158/1538-7445.am2018-1630 ◽

2018 ◽

Cited By ~ 1

Author(s):

Christopher D. Chien ◽

Lila Yang ◽

Sang M. Nguyen ◽

Christopher T. Sauter ◽

Kazusa Ishii ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

Infant Acute Lymphoblastic Leukemia

Lymphoblastic Leukemia ◽

Cell Lineage ◽

Antigen Receptor ◽

T Cell Therapy ◽

Lineage Switch ◽

Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia

Medicine ◽

10.1097/md.0000000000025786 ◽

2021 ◽

Vol 100 (19) ◽

pp. e25786

Author(s):

Fu Ming Zi ◽

Long Long Ye ◽

Ji Fu Zheng ◽

Jing Cheng ◽

Qing Ming Wang

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

Jak Inhibitor ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

T Cell Therapy

Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia

Current Treatment Options in Oncology ◽

10.1007/s11864-020-0706-6 ◽

2020 ◽

Vol 21 (2) ◽

Cited By ~ 5

Author(s):

Talha Badar ◽

Nirav N. Shah

Keyword(s):

T Cell ◽

Cell Therapy ◽

Lymphoblastic Leukemia ◽

Antigen Receptor ◽

T Cell Therapy